On December 29, 2014, AVEO Pharmaceuticals (Nasdaq: AVEO) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE